Black Rock Inc. Eye Point Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,787,359 shares of EYPT stock, worth $23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,787,359

Previous 2,169,306 28.49%

Holding current value

$23 Million

Previous $50.1 Million 14.92%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$19.93 - $29.71 $12.3 Million - $18.4 Million	618,053 Added 28.49%	2,787,359 $57.6 Million
Q4 2023 Feb 13, 2024	BUY	$5.71 - $24.13 $1.94 Million - $8.2 Million	339,856 Added 18.58%	2,169,306 $50.1 Million
Q3 2023 Nov 13, 2023	BUY	$7.99 - $15.36 $613,456 - $1.18 Million	76,778 Added 4.38%	1,829,450 $14.6 Million
Q2 2023 Aug 11, 2023	BUY	$3.03 - $9.0 $695,697 - $2.07 Million	229,603 Added 15.08%	1,752,672 $15.2 Million
Q1 2023 May 12, 2023	SELL	$2.28 - $5.04 $354,298 - $783,185	-155,394 Reduced 9.26%	1,523,069 $4.48 Million

Q4 2022 Feb 13, 2023	BUY	$2.37 - $7.2 $65,018 - $197,524	27,434 Added 1.66%	1,678,463 $5.87 Million
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.12 $572,578 - $914,809	82,267 Added 5.24%	1,651,029 $13.1 Million
Q2 2022 Aug 12, 2022	BUY	$7.25 - $12.71 $308,915 - $541,560	42,609 Added 2.79%	1,568,762 $12.3 Million
Q1 2022 May 12, 2022	BUY	$8.67 - $14.11 $741,475 - $1.21 Million	85,522 Added 5.94%	1,526,153 $18.5 Million
Q4 2021 Feb 10, 2022	BUY	$10.18 - $18.4 $2.54 Million - $4.6 Million	249,998 Added 21.0%	1,440,631 $17.6 Million
Q3 2021 Nov 09, 2021	BUY	$7.51 - $11.72 $457,276 - $713,619	60,889 Added 5.39%	1,190,633 $12.4 Million
Q2 2021 Aug 11, 2021	BUY	$8.69 - $11.08 $9.82 Million - $12.5 Million	1,129,744 New	1,129,744 $10.2 Million

Others Institutions Holding EYPT

# of Institutions

176

Shares Held

53.9M

Call Options Held

764K

Put Options Held

1.57M

View Full List

About EyePoint Pharmaceuticals, Inc.

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $281M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

More about EYPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account